Innate immune responses are essential to host defense, yet if unchecked can lead to tissue injury and illness (1) . PMN are the primary initial immune eff ectors of acute infl ammation, and these cells use as many as fi fty toxins for microbial killing in phagocytic vacuoles (2) . Incomplete closure of phagolysosomes or aberrant extracellular release of reactive oxygen species (ROS), granule components, lipid mediators, hypochlorous acid, and other potentially toxic PMN products to surrounding tissues contribute to injury in several human diseases, including the devastating clinical entities of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) for which no disease-remitting therapy is currently available (3) .
To prevent an overexuberant infl ammatory response and limit damage to the host, PMN activation programs need to be tightly controlled (1) . Select membrane-derived lipid mediators have recently been described as autacoid regulators of PMN functional responses in acute infl ammation (4) . One of these classes of antiinfl ammatory membrane lipids involves isoprenoid metabolism. Immune regulatory roles for isoprenoids are emphasized by the hyper-IgD and periodic fever syndrome that results from low polyisoprenyl phosphate (PIPP) levels secondary to defective mevalonate kinase activity (5) . Recently, we identifi ed a novel PIPP signaling pathway in PMN (6) . One of its components is presqualene diphosphate (PSDP), pres ent in freshly isolated human PMN in nanomolar quantities at baseline (i.e., 1.7 nmol/10 7 cells) (6) . PMN exposure to the chemoattractant and secretagogue leukotriene B 4 (LTB 4 ) initiates transient activation of this PIPP signaling pathway with conversion of PSDP to its monophosphate form, presqualene monophosphate (PSMP). PSDP carries biological
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Neutrophils play a central role in host defense, infl ammation, and tissue injury. Recent fi ndings indicate a novel role for polyisoprenyl phosphates (PIPPs) as natural downregulatory signals in neutrophils. The relationship between PIPPs and neutrophil early activating signals, such as phosphoinositides, has not been previously determined. Here, we establish presqualene diphosphate (PSDP) as an endogenous PIPP regulator of phosphatidylinositol 3-kinase (PI3K). In human neutrophils, leukotriene B 4 (LTB 4 ) triggered rapid decreases in PSDP and reciprocal increases in PI3K activity. In addition, PSDP was identifi ed by gas chromatography/mass spectrometry in p110 -PI3K immunoprecipitates obtained 30 s after LTB 4 , indicating a physical interaction between PSDP and PI3K in activated neutrophils. Moreover, PSDP (0.4-800 pmol) directly inhibited recombinant human p110 -PI3K activity. During an experimental model of lung injury and infl ammation, a reciprocal relationship was also present in vivo for lung PSDP and PI3K activity.
To investigate its therapeutic potential, we developed a new PSDP structural mimetic that blocked human neutrophil activation and mouse lung PI3K activity and infl ammation. Together, our fi ndings indicate that PSDP is an endogenous PI3K inhibitor, and suggest that in infl ammatory diseases characterized by excessive neutrophil activation, PIPPs can serve as structural templates in a novel antineutrophil therapeutic strategy to limit tissue injury.
activity as a potent counterregulatory mediator that prevents ROS generation (6, 7) . In sharp contrast, PSMP is >100-fold less active than PSDP for inhibition (6, 7) . Thus, incoming positive signals for PMN (e.g., LTB 4 ) initiate rapid degradation and inactivation of an inhibitory lipid signal (i.e., PSDP) coincident with cell responses (e.g., ROS generation). PSDP levels quickly return to baseline in a time frame that parallels cellular deactivation. Intracellular targets for PSDP to control PMN activity remain to be elucidated. Select PSDP structural mimetics are also active in vivo, dampening mouse responses to zymosan A-induced peritonitis (8) .
In addition to PSDP remodeling, LTB 4 also initiates phosphatidylinositol 3-kinase (PI3K) activation in PMN to promote NADPH oxidase assembly and ROS production (9, 10) . Phosphoinositide signaling initiated by PI3Ks is a critical early event in PMN responses, such as phagocytosis (11) and chemotaxis (12) , and contributes to ALI pathogenesis (13) . Because LTB 4 initiates PMN PI3K activation and PIPP remodeling, we hypothesized that these signaling events were related in the regulation of PMN responses. Here, we report that PI3K activity and PSDP remodeling are linked during PMN activation and deactivation with direct inhibition of PI3K by PSDP to limit PMN responses and lessen the severity of experimental lung infl ammation.
RESULTS AND D I S C U S S I O N PSDP and PI3K regulate LTB 4 -triggered O 2 − release by human PMN
To determine if PSDP and PI3K regulate LTB 4 -stimulated responses, we exposed freshly isolated human PMN to a new structural PSDP mimetic ( Fig. 1 A) or a potent and specifi c inhibitor of PI3K activity (LY294002) before LTB 4 . A marked increase in the rate of O 2 − generation was observed within seconds after LTB 4 addition that was transient, slowing considerably by 60 s (Fig. 1 B) . The presence of either PSDP mimetic (100 nM) or PI3K inhibitor (3 μM) markedly blocked O 2 − generation. Exposure to LTB 4 (10 min) induced 1.6 ± 0.3 nmol O 2 − /10 6 PMN (as compared with vehicle 0.5 ± 0.1 nmol O 2 − /10 6 PMN; P < 0.01). Both the PSDP mimetic and PI3K inhibitor led to >50% inhibition of LTB 4 -triggered O 2 − generation (0.8 ± 0.3 nmol/10 6 PMN and 0.7 ± 0.2 nmol/10 6 PMN, respectively; P < 0.05) ( Fig.  1 C) . The PSDP mimetic concentration in these experiments (i.e., 100 nM) was 1,000-fold lower than its critical micellar concentration (CMC) ‫001ف(‬ μM; Fig. S1 , at http://www. jem.org/cgi/content/full/jem.20052143/DC1). To verify that the observed inhibition was not secondary to micelle formation and sequestration of the lipid agonist LTB 4 , in the next experiments, there was pretreatment with the mimetic, a wash, and stimulation with LTB 4 . Although this extra step reduced total ROS generation in response to LTB 4 , the PSDP mimetic still led to a >50% decrease (71.2 ± 27.7% inhibition, n = 4). Together, these results indicate that human PMN activation by LTB 4 is highly dependent on PI3K activity and can be inhibited by a new PSDP structural mimetic.
Relationship between PI3K activity and PSDP during PMN activation
To determine if PSDP remodeling and PI3K activation were related, we fi rst examined their kinetics in human PMN after exposure to LTB 4 . Because G protein-coupled receptors can activate class IA and IB PI3Ks (10), we measured PIP 3 formation in vitro by members of these PI3K classes. After LTB 4 , p110γ-PI3K activity in PMN rapidly increased (within 5 s), reached a maximum rate of activity by 20 s, and then declined to basal levels within 30 s ( Fig. 2 A, representative for n = 3). LTB 4 also rapidly stimulated p85-based PI3K activity in PMN, but at lower levels than p110γ-PI3K. By 5 s, signifi cant decrements were also evident in total PSDP levels (7.9 ± 1.2%; P < 0.01) (see supplemental 
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Materials and methods, available at http://www.jem.org/ cgi/content/full/jem.20052143/DC1) that progressed to 27.1 ± 4.8% reductions (P = 0.001) within 30 s (Fig. 2 B) .
These results indicate that LTB 4 -triggered activation of PMN PI3K and PSDP remodeling was concurrent and temporally overlapped with initiation of ROS generation. Although both of these signaling events were rapid in onset, the kinetics for PI3K activation and deactivation diff ered from the time course for total PSDP remodeling during the initial 30-s interval. To determine if PSDP directly interacted with PI3K as its activity decreased, PMN were exposed to LTB 4 for 30 s and p110γ−PI3K was immunoprecipitated from cellular materials. Lipid extracts were performed and analyzed by gas chromatography/mass spectrometry (GC/MS) (6) . Selective ion monitoring at m/z 137 (2 isoprenoid units) revealed a unique peak at 18.1 min in LTB 4 -exposed PMN extracts. MS spectral diagnostic ions (Fig. 2 C) 
Direct inhibition of p110 -PI3K by PSDP
Because PI3K activity and PSDP remodeling were both early signaling events in PMN with interaction between PSDP and p110γ-PI3K, next we questioned if PSDP could directly regulate PI3K activity. Recombinant human (rh) p110γ-PI3K activity was determined by PIP 3 formation in vitro in the presence of PSDP, PSMP, or the PI3K inhibitor LY294002. PIP 3 formation was signifi cantly decreased by PSDP (800 pmol) with 94.7 ± 5.3% inhibition (P < 0.001) and a PI3K inhibitor (500 pmol) with 46.7 ± 6.7% inhibition (P = 0.01) ( Fig. 3 A) . PSDP inhibited p110γ-PI3K in a concentrationdependent fashion (Fig. 3 B) . In sharp contrast, PSMP (8-800 pmol) did not signifi cantly impact p110γ-PI3K activity. The IC 50 for PSDP (38 pmol) had a stoichiometry with PI3K of ‫.1:9ف‬ These results indicate that PSDP is a potent direct inhibitor of p110γ-PI3K with a structure-activity relationship that suggests an important role for the diphosphate structure in PSDP's action on p110γ-PI3K activity. The LTB 4 -mediated PMN remodeling of PSDP corresponds to an ‫05ف‬ pmol change in PSDP/10 6 PMN, a decrease that is within the concentration range for regulation of p110γ-PI3K activity ( Fig. 3 B) . After cell activation, the percent change in total PSDP (i.e., 28%) is similar to the change in phosphatidylinositol (17%) that occurs in activated PMN membranes (14) . Collectively, our new fi ndings indicate that receptormediated agonists for PMN remodel PSDP in time-frames and amounts consistent with functional impact on PI3K activity and cellular responses.
PSDP remodeling in vivo during tissue injury and infl ammation
Because PI3K activity occupies a central role in regulating PMN activation during lung injury and infl ammation (13), next we determined PSDP remodeling in vivo in mouse lungs during an experimental model of mild ALI secondary to aspiration of gastric acid (15) , which is a common clinical event (3). To simulate acid aspiration, hydrochloric acid (HCl) (0.1 N, pH = 1.5) was selectively instilled into the animals' left lungs (15) . Lung PMN infi ltration was maximal 12 h after HCl injury (14.2 ± 1.8 vs. 5.5 ± 0.8 × 10 4 PMN/mg lung; P < 0.01) ( Fig. 4 A) . Expression of class IA and IB PI3Ks in mouse lungs were both increased at 2 and 12 h after HCl (Fig. 4 B) . Lungs were removed and lipid extracts were prepared for PSDP determination. Of interest, despite increased PMN numbers, PSDP levels were signifi cantly lower in the left lungs of HCl-injured mice (4.6 ± 0.3 μg PSDP vs. 9.0 ± 1.6 μg PSDP in control lungs; P < 0.02). These results indicate that experimental lung injury led to decrements in PSDP concomitant with increased PMN, suggesting an inverse relationship in vivo between lung PSDP and infl ammation.
PSDP mimetic blocks PMN infi ltration and PI3K activity
To determine if PSDP can block pulmonary infl ammation and PI3K in vivo, we administered a PSDP structural mimetic (0.8 μg/mouse, i.v.) or vehicle 15 min before HCl instillation into the left main-stem bronchus. PSDP markedly reduced lung PMN 12 h after injury ( Fig. 5 A) . Tissue morphometry on LY-6G-stained histological sections (for identifi cation of mouse PMN) revealed signifi cant inhibition with the PSDP mimetic (46.8 ± 7.1% LY-6G staining [HCl] vs. 18.8 ± 5.8% LY-6G staining [HCl plus PSDP mimetic]; P < 0.05) (Fig.  5 B) . In view of the prominent class IA PI3K lung expression that increased markedly after ALI ( Fig. 4 B) , we next determined class IA PI3K activity after acid injury in the presence or absence of the PSDP mimetic. HCl injury induced significant increases in lung PI3K activity in p85 immunoprecipitates (0.59 ± 0.17 PIP 3 /mg lung with HCl vs. 0.05 ± 0.02 pmol PIP 3 /mg lung with PBS; P < 0.05). Administration of the PSDP mimetic blocked the HCl-induced increase in class IA PI3K activity to near basal levels (0.05 ± 0.01 pmol PIP 3 /mg lung; P < 0.05) ( Fig. 5 C) . Thus, PSDP can regulate PMN activation, tissue accumulation, and total PI3K activity in vivo during experimental acid-initiated ALI.
During acute infl ammation, PI3Ks orchestrate several cellular responses for host defense, including PMN ROS generation (12) . Befi tting its central role in cell activation, several mechanisms are in place to restrain PI3K activity (16) (17) (18) . Previous reports have suggested a link between decreased PIPP formation and increased PI3K (19, 20) . Results presented here are the fi rst to demonstrate direct inhibition of PI3K by a PIPP and inverse relationships between PI3K activity and PSDP levels both in vitro and in vivo. In addition, PSDP bound to p110γ-PI3K in activated PMN and potently inhibited rhp110γ-PI3K in vitro and a PSDP structural mimetic blocked PI3K activity in vivo. Together, these new fi ndings support a signaling relationship between PI3K and PIPPs in the regulation of leukocyte functions during infl ammation.
Pivotal regulatory properties have been ascribed to isoprenoids. For example, polyisoprenyl glycolipids form antigen complexes with CD1 to activate T cells (21) , and cholesterol is critical to PMN cell membrane organization and polarization in response to chemotactic stimuli (22) . Although PIPPs are appreciated as cholesterol biosynthetic intermediates, PSDP is also present in cells, such as human PMN, that cannot use it for cholesterol biosynthesis because they lack squalene cyclase and other mixed function oxidase activities (23) . There are now several lines of evidence to support a role for PSDP as a counterregulatory signal in PMN functional responses. PSDP is a constituent of PMN cell membranes (20) , and receptor activation leads to rapid and transient PIPP remodeling. PSDP is a potent and direct inhibitor of phospholipase D (PLD) with at least two interaction domains on human PLD1b for PSDP (8) . PSDP also interacts with Src-homology 2 (SH2) domains on the adaptor protein Grb2 (24) and blocks NADPH oxidase assembly in a cell-free assay (6) . PSDP displays anti-PMN properties in vitro and in vivo, and PSDP structural mimetics are able to dampen leukocyte-driven infl ammation (8) . Here, we have identifi ed PI3K as a new target for regulation by PSDP. The physical interaction between PI3K and PSDP and absence of regulatory proteins in our in vitro system indicate that PSDP can directly inhibit p110γ-PI3K. Similar to PLD (8), the diphosphate moiety of PSDP was also important for PI3K inhibition, and the stoichiometry suggests multiple potential sites for PSDP and PI3K interaction. Both class IA and IB PI3Ks translocate to membranes via interactions with Ras that is activated, in part, via isoprenylation (25) . These shared isoprenoid moieties with PSDP may provide additional sites of interaction outside the PI3K catalytic center. Of interest, PSDP and PI3K are present in resting PMN in complementary intracellular locations (cell membranes and cytosol, respectively), and both translocate to intracellular organelles upon cell activation (20, 26) .
Activated PMN contribute to the development and severity of tissue injury during infl ammatory illnesses such as ALI. No specifi c therapy is currently available to modulate the infl ammatory response to airway injury from acid and protect the lung in ALI. PI3K is an important enzyme in the proinfl ammatory PMN signaling program of ALI, as p110γ-PI3K defi ciency dampens the severity of endotoxin-induced ALI (13) . In addition to PMN, PI3Ks are also activated during ALI in lung-resident cells (27) and both endothelial cell and PMN PI3Ks contribute to PMN accumulation in the lung (28) . Select lipid mediators, namely lipoxin A 4 (LXA 4 ), inhibit PI3K in structural cells (29) . LXA 4 signaling also promotes resolution of experimental ALI (15) and inhibits PMN activation by LTB 4 in a postreceptor manner, in part by blocking PSDP remodeling (7) . Here, PSDP levels were decreased in acid-injured lungs and a novel PSDP mimetic blocked PI3K, PMN ROS generation, and PMN accumulation in the lung. Because the PSDP mimetic was administered intravenously, regulation of cells other than PMN may have also contributed to the marked inhibition of leukocyte traffi cking after acid injury.
In conclusion, the ability of PSDP and a new PSDP mimetic to directly inhibit PMN early intracellular activating signals, such as PI3K, and to lessen the infl ammation associated with experimental ALI provides insight into new mechanisms for in vivo protection from excess PMN-driven infl ammation and tissue injury. Together, our fi ndings suggest that PIPP signaling pathways, and specifi cally PSDP, can serve as natural templates for the design of new therapeutic strategies in infl ammatory diseases.
